Pharma IQ Members

Transportation & Logistics
25 results
of 3
Contributor: Cathy Roberson
Posted: 27/07/2016
Cathy
Imagine, a doctor sends a prescription to a pharmacy that uses a 3D printer to create a custom formulation based on the special needs of a patient or perhaps a patient is able to print his own medications from home with raw materials purchased at a pharmacy or who knows, delivered via drone or by an autonomous delivery truck. This futuristic outlook involving cost shifting to the patient is not likely to occur soon. The requirement of purchasing a printer and raw materials could be prohibitive for many. It also would raise numerous quality control and regulatory questions. Full Content »
Contributor: Mark Edwards
Posted: 13/07/2016
Mark Edwards
Back in November 2015, I highlighted the new regulations regarding container weight declarations (Verification of Gross Mass or VGM) which came under the International Convention for the Safety of Life at Sea, more commonly known as SOLAS. These were adopted in November 2014 and came into force from 1st July 2016. Full Content »
Contributor: Gary Hutchinson
Posted: 29/06/2016
Gary Hutchinson
Clinical trial material (CTM) or investigational medicinal products (IMP) are an important part of the early stages of the life science supply chain. As trials are being run on a global scale, in markets with less than ideal infrastructure, there is a dire need for companies to work with specialized cold chain experts to engineer and design innovative distribution processes.
Cold chain failure may lead to: the patient being administered an unsafe product; liability based on compliance infractions; inconsistent data results; or an entire shipment’s product integrity could be rejected by the quality department, resulting in costly delays. Full Content »
Contributor: Cold Chain IQ
Posted: 15/06/2016
Cold Chain IQ
Ahead of the 14th Cold Chain - GDP & Temperature Management Logistics Global Forum, Cold Chain IQ looks at the concept of global standardization with risk management in the cold chain. This whitepaper explores supply chain security and validation as they pertain to lane qualification, data monitoring, shipping lanes and stability budgets. Full Content »
Contributor: Cathy Roberson
Posted: 15/06/2016
Cathy
The sensor is advancing beyond the containers and packages and is leading the Internet of Things wave to such areas as wearables to implantables, smart homes to smart cities. The pharmaceutical industry will benefit greatly from such advances and will further usher in the digital healthcare discipline. Imagine the supply chain implications. Full Content »
Contributor: Cold Chain IQ
Posted: 01/06/2016
Cold Chain IQ
Since 2012, Cold Chain IQ has acted as an international resource center for temperature control life science professionals, delivering insightful, unbiased information about the latest ‘hot topics’. Full Content »
Contributor: Alan Kennedy
Posted: 01/06/2016
Alan k
It’s lips may pay service but much of the pharma-logistics sector remains dormant when it comes to genuine supply chain integration. Full Content »
Contributor: Gary Hutchinson
Posted: 24/05/2016
Gary Hutchinson
Documentation strategy for your cold chain management validation practices has evolved over the last several years. The FDA and other regulatory agencies are requesting more and more specific information in the filing to confirm the impact to drug product during transport, and the effect transportation hazards have on shelf life. Full Content »
Contributor: Cold Chain IQ Surveys
Posted: 04/05/2016
Cold Chain IQ Surveys
Cold Chain IQ would like to invite you to take part in this short industry survey.

The survey will take 10 minutes to complete and as a thank you, all participants who complete the survey can choose to be entered into a PRIZE DRAW for a complimentary pass to Temperature Controlled Logistics 2017 in London- With the event's usual entry fee standing at £1499. Full Content »
Contributor: Miss Chanice Henry
Posted: 04/05/2016
Miss Chanice Henry
China’s State Council has passed an amendment on vaccine regulations just weeks after the launch of an investigation into incorrectly handled vaccines took place, in ‘a case that shook the country’. Full Content »
Contributor: Cathy Roberson
Posted: 27/04/2016
Cathy
For healthcare professionals, the use of drones has huge benefits in particular the ability to reach remote areas that lack proper infrastructure to deliver lifesaving drugs and other necessities. Many tests are underway to determine its viability but as one can imagine, it is under much government scrutiny and regulators in many countries are working with the industry to develop requirements for the delivery and flying of drones. Full Content »
25 results
of 3
Contributor: Chanice Henry
Posted: 08/04/2016
Chan
Jeff Carrico, Director of Pharmacy - Investigational Drug Service at Florida Hospital System and Member, Expert Committee, Packaging and Distribution, U.S. Pharmacopeia provides an overview of overarching chapters on Good Distribution Practices. Full Video »
Contributor: Cathy Roberson
Posted: 27/07/2016
Cathy
Imagine, a doctor sends a prescription to a pharmacy that uses a 3D printer to create a custom formulation based on the special needs of a patient or perhaps a patient is able to print his own medications from home with raw materials purchased at a pharmacy or who knows, delivered via drone or by an autonomous delivery truck. This futuristic outlook involving cost shifting to the patient is not likely to occur soon. The requirement of purchasing a printer and raw materials could be prohibitive for many. It also would raise numerous quality control and regulatory questions. Full Column »
Contributor: Cold Chain IQ
Posted: 15/06/2016
Cold Chain IQ
Ahead of the 14th Cold Chain - GDP & Temperature Management Logistics Global Forum, Cold Chain IQ looks at the concept of global standardization with risk management in the cold chain. This whitepaper explores supply chain security and validation as they pertain to lane qualification, data monitoring, shipping lanes and stability budgets. Full Whitepaper »